Cannabis compound may benefit children with epilepsy
27 November, 2018Researchers reviewing studies around the medical use of cannabidiol have found the treatment to be moderately effective in two forms of childhood epilepsy.
Immunotherapy trial for MS shows early positive results
21 November, 2018A new cellular immunotherapy treatment that targets the Epstein-Barr virus (EBV) has been found to improve multiple sclerosis (MS) symptoms.
Online tool predicts how cells repair broken DNA
19 November, 2018Researchers have created a machine learning model, inDelphi, that predicts how human and mouse cells respond to CRISPR-induced breaks in DNA.
LogicBio, CMRI partner to develop next-gen viral vectors
19 November, 2018Genome editing company LogicBio has partnered with the Children's Medical Research Institute to fast-track gene therapy treatments for children with life-threatening genetic liver disease.
AusCann set to launch cannabinoid medicine for chronic pain
15 November, 2018AusCann's hard-shell capsules will target the estimated 1.9 million Australians who suffer chronic neuropathic pain.
Liver fluke key to chronic wound treatment
08 November, 2018Researchers have developed a promising new treatment for chronic wounds, utilising a protein isolated from a surprising source — a parasitic Thai liver fluke.
Collaboration to accelerate early-stage drug discovery
07 November, 2018Biomedical research company BioCurate and pharmaceutical company Novartis have announced they will collaborate on early-stage drug discovery projects.
Plant peptide shows promise in antifungal trial
05 November, 2018Biotechnology company Hexima has announced promising results for its plant defensin peptide, HXP124, in fungal nail infections.
100% human skin graft developed
01 November, 2018Researchers have made a skin graft cell culture using only human cells, which could be used to provide safer treatment for severe burns and other skin conditions in the future.
New PBS listings benefit lung cancer, cholesterol patients
30 October, 2018Two new listings on the Pharmaceutical Benefits Scheme have the potential to extend the lives of Australians with advanced lung cancer and those at risk of a heart attack.
Investigational antibiotic shows promise in UTIs
26 October, 2018A new investigational antibiotic is proving as effective as the current standard-of-care antibiotic for the treatment of complicated UTIs caused by several multidrug-resistant Gram-negative bacteria.
Studying the use of CRISPR on human liver-on-a-chip platform
22 October, 2018Two US researchers are combining their expertise in CRISPR technology and human microphysiological systems to assess the safety and efficacy of genome editing.
Same-sex mice reproduce via gene editing
15 October, 2018Researchers from the Chinese Academy of Sciences have produced healthy mice with two mothers that went on to have normal offspring of their own.
How could gene editing serve NZ's primary industries?
05 October, 2018Removing allergens from milk, making mānuka disease resistant and preventing wilding pines are some potential future uses of gene editing in New Zealand.
Liposoma clodronate liposomes
04 October, 2018Liposoma's clodronate liposomes are artificial spheres consisting of concentric phospholipid bilayers encapsulating an aqueous PBS (phosphate buffered saline) solution containing clodronate.
